Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Depreciation & Amortization (CF) (2010 - 2020)

Grifols' (GIFLF) quarterly Depreciation & Amortization (CF) came in at $85.6 million in Q1 2020, up 1.15% on a YoY basis from $84.7 million in Q2 2019, and down 65.48% quarter-over-quarter from $248.1 million in Q4 2019.

Analysis

Grifols (GIFLF) Depreciation & Amortization (CF) (2010 - 2020) Analysis & Trends

Grifols (GIFLF) has reported Depreciation & Amortization (CF) for 11 consecutive years, with $85.6 million the latest figure, recorded in Q1 2020.

  • For the quarter ending Q1 2020, Depreciation & Amortization (CF) rose 1.15% year-over-year to $85.6 million; the trailing twelve-month figure through Dec 2025 stood at $0.0 (changed 0.0% YoY), and the FY2025 full-year result was $508.4 million, up 8.63% from the prior year.
  • Depreciation & Amortization (CF) eased to $85.6 million in Q1 2020 per GIFLF's latest filing, from $248.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.4 billion in Q4 2016 and bottomed at -$1.1 billion in Q2 2016.
  • Historically, Depreciation & Amortization (CF) has averaged $198.2 million across 5 years, with a median of $84.7 million in 2019.
  • The widest YoY moves for Depreciation & Amortization (CF): up 2345.14% in 2016, down 2283.99% in 2016.
  • Over 5 years, Depreciation & Amortization (CF) stood at $1.4 billion in 2016, then sank by 86.64% to $186.5 million in 2017, then grew by 1.84% to $189.9 million in 2018, then jumped by 30.64% to $248.1 million in 2019, then sank by 65.48% to $85.6 million in 2020.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $85.6 million, $248.1 million, and $84.7 million for Q1 2020, Q4 2019, and Q1 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn 1.11 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn 56.50 Mn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn 123.70 Mn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn 236.10 Mn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn 600,000.00
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 85.64 Mn
Dec 31, 2019 248.08 Mn
Mar 31, 2019 84.66 Mn
Dec 31, 2018 189.89 Mn
Jun 30, 2018 65.73 Mn
Mar 31, 2018 64.97 Mn
Dec 31, 2017 186.46 Mn
Jun 30, 2017 58.53 Mn
Mar 31, 2017 56.80 Mn
Dec 31, 2016 1.40 Bn
Sep 30, 2016 55.63 Mn
Jun 30, 2016 -1.12 Bn
Mar 31, 2016 1.21 Bn
Dec 31, 2015 1.18 Bn
Sep 30, 2015 54.14 Mn
Jun 30, 2015 51.35 Mn
Mar 31, 2015 49.33 Mn
Dec 31, 2014 1.05 Bn
Sep 30, 2014 183.76 Mn
Jun 30, 2014 -63.47 Mn